Differentiating spontaneous from drug-induced vascular injury in the dog

Toxicologic Pathology

Volumn 31, Issue SUPPL., 2003, Pages 25-31

  Clemo, Frances A S ^a   Evering, Winston E ^b   Snyder, Paul W ^c   Albassam, Mudher A ^d  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

^b PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

^c PURDUE UNIVERSITY   (United States)

^d PFIZER INC   (United States)

Author keywords

Arteriopathy; Artery; Dog; Drugs; Phosphodiesterase inhibitors; Polyarteritis; Vasculitis; Vasoactive

Indexed keywords

3 (2 CARBOXYMETHOXY 4 METHOXYPHENYL) 1 (3,4 METHYLENEDIOXYPHENYL) 5 PROPOXY 2 INDANCARBOXYLIC ACID; 4 (4 METHOXYPHENYL) 2 (3,4 METHYLENEDIOXYPHENYL) 4 OXO 3 (3,4,5 TRIMETHOXYBENZYL) 2 BUTENOIC ACID; 5 (4 ACETAMIDOPHENYL) 2(1H) PYRAZINONE; 6 [4 (1,4 DIHYDRO 4 OXO 1 PYRIDYL)PHENYL] 4,5 DIHYDRO 5 METHYL 3(2H) PYRIDAZINONE; AMINOREX; BENZODIAZEPINE; CARPROFEN; CI 947; COTRIMOXAZOLE; DIGOXIN; DOBUTAMINE; DOPAMINE; ENDOTHELIN RECEPTOR ANTAGONIST; ERGOTAMINE; HYDRALAZINE; INOTROPIC AGENT; ISOPRENALINE; ITRACONAZOLE; METRONIDAZOLE; MINOXIDIL; NORADRENALIN; PHOSPHODIESTERASE III INHIBITOR; PHOSPHODIESTERASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SIGUAZODAN; SKF 94418; THEOBROMINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASOACTIVE AGENT; VASODILATOR AGENT;

ANIMAL DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; BLEEDING; BLOOD VESSEL INJURY; CLINICAL FEATURE; CONFERENCE PAPER; CORONARY ARTERY; DISEASE EXACERBATION; DOG; DRUG INDUCED DISEASE; HISTOPATHOLOGY; IDIOPATHIC DISEASE; INCIDENCE; INOTROPISM; NONHUMAN; POLYARTERITIS; PRIORITY JOURNAL; TOXICOLOGY; VASCULAR DISEASE; VASODILATATION; ADVENTITIA; ARTERY LESION; ARTICLE; BEAGLE; COMPARATIVE STUDY; DRUG INDUCED VASCULAR INJURY; IDIOPATHIC CANINE POLYARTERITIS;

ANIMALS; ARTERIES; DOG DISEASES; DOGS; DRUG EVALUATION, PRECLINICAL; MODELS, ANIMAL; POLYARTERITIS NODOSA; VASODILATOR AGENTS;

ANIMALIA; CANIS FAMILIARIS;

EID: 0037258303     PISSN: 01926233     EISSN: None     Source Type: Journal    
DOI: 10.1080/01926230309769     Document Type: Conference Paper

References (52)

1. Albassam MA, Houston BJ, Greaves P, Barsoum N (1989). Polyarteritis in a beagle. J Amer Vet Med Assos 194(11): 1595-1597.
2. Albassam MA, Metz AL, Potoczak RE, Gallagher KP, Haleen S, Hallak H, McGuire EJ (2001). Studies on coronary arteriopathy in dogs following adminstration of CI-1020, an endothelin A receptor antagonist. Toxciol Pathol 29(3): 277-284.
3. Bishop SP (1990). Animal models of vasculitis. Toxicol Pathol 17: 109-117.
4. Boor PJ, Gothlieb AI, Joseph EC, Kerns WD, Roth RA, Tomaszewki KI (1995). Chemical-induced vasculature injury. Toxicol Appl Pharmacol 132: 177-195.
5. Boor PJ, Hysmith RM (1987). Allylamine cardiovascular toxicity. Toxicology 44: 129-145.
6. Bourdois PS, Dancla JL, Faccini JM, Nachbaur J, Monro AM (1982). The subacute toxicology of digoxin in dogs; clinical chemistry and histopathology of heart and kidneys. Arch Toxicol 51: 273-283.
7. Brooks PN (1984). Necrotizing vasculitis in a group of beagles. Lab Anim 18: 285-290.
8. Calabrese LH, Duna GF (1996). Drug-induced vasculitis. Curr Opin Rheumatol 8: 34-40.
9. Chelly JE, Doursout MF, Begaud B, Tsao CC, Hartley CJ (1986). Effects of hydralazine on regional blood flow in conscious dogs. J Pharmacol Exp Ther 238: 665-669.
10. Conrad LL, Gonzalez IE, Joel L, Furman RH (1956). Histochemical evaluation of canine coronary artery and arotic lesions induced by intravenous allylamine. Circ Res 4: 263-267.
11. Gans JH, Korson R, Cater MR, Ackerly CC (1980). Effects of short-term and long-term theobromine administration to male dogs. Toxicol Appl Pharmacol 53:481-496.
12. Greaves P (1998). Patterns of drug-induced cardiovascular pathology in the beagle dog: Relevance for humans. Exp Toxic Pathol 50: 283-293.
13. Greaves P (2000). Patterns of cardiovascular pathology induced by diverse cardioactive drugs. Toxicol Lett 112-113: 547-552.
14. Griffith RW, Grauwiler J, Hodel CH, Leist KH, Matter B (1978). Toxicologic considerations. Ergot alkaloids and related compounds (1978). In: Handbook of Experimental Pharmacology, Vol. 49, Springer Verlag, Berlin. pp 805-851.
15. Gristwood RW, Comer MB, Eden RJ, Taylor EM, Turner JA, Wallduck M, Owen DAA (1988). In vivo pharmacological studies with SK&F 94836, a potent intrope/vasodilator with sustained duration of action. Br J Pharmacol 93: 893-901.
16. Harcourt RA (1978). Polyarteritis in a colony of beagles. Vet Rec 102: 519-522.
17. Harleman HJ, Joseph EC, Eden RJ, Walker TF, Major IR, Lamb MS (1986). Cardiotoxicity of a new inotrope/vasodilator drug (SK&F 94120) in the dog. Arch Toxicol 59: 51-55.
18. Hartman HA (1987). Idiopathic extramural coronary arteritis in beagle and mongrel dogs. Vet Pathol 24: 537-544.
19. Hayes TJ, Roberts GKS, Halliwell WH (1989). An idiopathic febrile necrotizing arteritis syndrome in the dog: Beagle pain syndrome. Toxicol Pathol 17(1): 129-137.
20. HogenEsch H, Snyder PW, Scott-Moncrieff CR, Glickman LT, Felsburg PJ (1995). Interleukin-6 activity in dogs with juvenile polyarteritis syndrome: Effects of corticosteroids. Clin Immunol Immunopathol 77(1): 107-110.
21. Humphery SJ, Zins GR (1984). Whole body and regional hemodynamic effects of minoxidil in the conscious dog. J Cardiovasc Pharmacol 6(6): 979-988.
22. Isaacs KR, Joseph EC, Betton GR (1989). Coronary vascular lesions in dogs treated with phosphodiesterase III inhibitors. Toxicol Pathol 17(1): 153-163.
23. 1 agonist. Toxicol Let 112-113: 537-546.
24. Joseph EC, Jones HB, Kerns WD (1996). Characterization of coronary arterial lesions in dog following administration of SK&F 95654, a phosphodiesterase III inhibitor. Toxicol Pathol 24(4): 429-435.
25. Joseph EC, Mesfin G, Kerns WD (1997). Pathogenesis of arterial lesions caused by vasoactive compounds in laboratory animals. In: Cardiovascular Toxicology, Bishop SP, Kerns WD (eds). Pergamon, New York, pp 279-307.
26. Kelly DK (1989). Classification of naturally occurring arterial disease in the dog. Toxicol Pathol 17(1): 77-93.
27. Kelly DK, Grunsell CSG, Kenyon CJ (1973). Polyarteritis in the dog: A case report. Vet Rec 92: 363-366.
28. Kemi M, Usui T, Narama I, Takahasji R (1990). Histopathology of spontanoeus panarteritis in beagle dogs. Jpn J Vet Sci 52(1): 55-61.
29. Kerns WD, Roth L, Hosokawa S (2001). Idiopathic canine polyarteritis. In: Pathology of the Ageing Dog, Vol 2, Mohr U, Carlton WW, Dungworth DL, Benjamin SA, Capen CC, Hahn FF (eds). Iowa State University Press, Ames, IA, pp 118-126.
30. Legendre AM (1995). Antimycotic drug therapy. In: Kirk's Current Veterinary Therapy XIII, Small Animal Practice, Bonagura JD (ed). WB Saunders, Philadelphia, pp 327-331.
31. Louden C, Nambi P, Branch C, Gossett K, Pullen M, Eustis S, Solleveld HA (1998). Coronary arterial lesions in dogs treated with an endothelin receptor antagonist. J Cardiovasc Pharmacol 31 (Suppl 1): S384-S385.
32. Louden S, Nambi P, Pullen MA, Thomas RA, Tierney LA, Solleveld HA, Schwartz LW (2000). Endothelin receptor subtype distribution predisposes coronary arteries to damage. Am J Pathol 157: 123-134.
33. Mesfin GM, Piper RC, DuCharme DW, Carlson RG, Humphrey SJ, Zins GR (1989). Pathogenesis of cardiovascular alterations in dogs treated with minoxidil. Toxicol Pathol 17(1): 164-181.
34. Mesfin GM, Robinson FG, Higgins MJ, Zhong WZ, DuCharme DW (1995). The pharmacology basis of the cardiovascular toxicity of minodoxil in the dog. Toxicol Pathol 23(4): 498-506.
35. Mesfin GM, Shawaryn GG, Higgins MJ (1987). Cardiovascular alterations in dogs treated with hydralazine. Toxicol Pathol 15(1): 409-416.
36. Metz AL, Dominick MA, Suchanek G, Gough AW (1991). Acute cardiovascular toxicity induced by an adenosine agonist-antihypertensive in Beagles. Toxicol Pathol 19(2): 98-107.
37. Morishima H, Nonoyama T, Sasaki S, Miyajima H (1990). Spontaneous lesions in beagle dogs used in toxicity studies. Exp Anim 39(2): 239-248.
38. Morris DO, Beale KM, Cutaneous vasculitis and vasculopathy (1999). Vet Clin North Amer: Small Anim Pract 29(6): 1325-1335.
39. Randall MG, Hurvitz AI (1983). Immune-mediated vasculitis in five dogs. J Amer Vet Med Assoc 183(2): 207-211.
40. Ruben Z, Deslex P, Nash G, Redmond NI, Poncet M, Dodd DC (1989). Spontaneous disseminated panarteritis in laboratory beagle dogs in a toxicity study: A possible genetic predilection. Toxicol Pathol 17 (1): 145-152.
41. Sandusky GE, Means JR, Todd GC (1990). Comparative cardiovascular toxicity in dogs given inotropic agents by continuous intravenous infusion. Toxicol Pathol 18(2): 268-278.
42. Schlaeppi B, Roncari G, Zahm P (1991). Vascular toxicity in dogs associated with overdoses of a novel benzodiazepine receptor partial agonist. Arch Toxicol 65(1): 73-80.
43. Scott-Moncrieff JCR, Snyder PW, Glickman LT, Davis EL, Felsburg PJ (1992). Systemic necrotizing vasculitis in nine young beagles. J Amer Vet Med Assoc 201(10): 1553-1558.
44. Snyder PW, Kazacos EA, Scott-Moncrieff JC, HogenEsch H, Carlton WW, Glickman LT, Felsburg PJ (1995). Pathologic features of naturally occurring juvenile polyarteritis in Beagle dogs. Vet Pathol 32: 337-345.
45. Spencer A, Greaves P (1987) Periarteritis in a beagle colony. J Comp Path 97: 121-128.
46. Stejskal V, Havu N, Malmfors T (1982). Necrotizing vasculitis as an immunological complication in toxicity study. Arch Toxicol Suppl 5: 283-286.
47. Stephen-Gueldne M, Inomata A, Coronary arterial lesions induced by endothelin antagonists (2000). Toxicol Lett 112-113: 531-535.
48. Teske RH, Bishop SP, Righter HF, Detweiler DK (1976). Subacute digoxin toxicosis in the beagle dog. Toxicol Appl Pharmacol 35: 283-301.
49. Uprichard ACG, Metz AL, Hallak H, Haleen SJ (1998). PD 156707: A selective endothelin-A receptor antagonist. Cardiovas Drug Rev 16(2): 89-104.
50. Van Vleet JF, Ferrans VJ, Herman E (1991). Cardiovascular and skeletal muscle systems. In: Handbook of Toxicology Pathology, Haschek WM, Rousseaux CG (eds). Academic Press, Inc, San Diego, pp 539-624.
51. Waters LI, DeSuto-Nagy GI (1950). Lesions of the coronary arteries and great vessels of the dog following injection of adrenalin. Their prevention by dibenamine. Science 111: 634-635.
52. Will JA, Bisgard GE (1972). Haemodynamic effects of oral aminorex and amphetamine in unanesthetized beagle dogs. Thorax 27: 120-126.